MedTrace Logo

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

NCT05807984 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-04-11

No results posted yet for this study

Summary

Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)

Conditions

Interventions

RADIATION

Carbon ion radiation therapy DT: 74Gy/20 fractions

patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation

Sponsors & Collaborators

  • Xin Cai

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05807984 on ClinicalTrials.gov